Early outcomes associated with de novo once‐daily extended‐release versus twice‐daily immediate‐release tacrolimus in a predominantly African American kidney transplant population: A single‐center observational study

Ähnliche Einträge

• BK polyomavirus DNAemia, allograft rejection, and de novo donor‐specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients
  von: Hou‐Xuan Huang, et al.
  Veröffentlicht: (2024)
• Successful use of eculizumab in immediate ANCA vasculitis recurrence in a pediatric kidney transplant
  von: Caitlin G. Peterson, et al.
  Veröffentlicht: (2024)
• Comparison of tacrolimus vs. cyclosporine in pediatric hematopoietic stem cell transplantation for thalassemia
  von: Suleimen Zhumatayev, et al.
  Veröffentlicht: (2024)
• Expanding the access to kidney transplantation: Strategies for kidney transplant programs
  von: Angie G. Nishio Lucar, et al.
  Veröffentlicht: (2024)
• Impact of race‐neutral eGFR calculations on African American kidney transplant candidate wait time: A single center retrospective analysis
  von: Rafael Khaim, et al.
  Veröffentlicht: (2024)